Your browser doesn't support javascript.
loading
International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents.
Casey, Ruth T; Hendriks, Emile; Deal, Cheri; Waguespack, Steven G; Wiegering, Verena; Redlich, Antje; Akker, Scott; Prasad, Rathi; Fassnacht, Martin; Clifton-Bligh, Roderick; Amar, Laurence; Bornstein, Stefan; Canu, Letizia; Charmandari, Evangelia; Chrisoulidou, Alexandra; Freixes, Maria Currás; de Krijger, Ronald; de Sanctis, Luisa; Fojo, Antonio; Ghia, Amol J; Huebner, Angela; Kosmoliaptsis, Vasilis; Kuhlen, Michaela; Raffaelli, Marco; Lussey-Lepoutre, Charlotte; Marks, Stephen D; Nilubol, Naris; Parasiliti-Caprino, Mirko; Timmers, Henri H J L M; Zietlow, Anna Lena; Robledo, Mercedes; Gimenez-Roqueplo, Anne-Paule; Grossman, Ashley B; Taïeb, David; Maher, Eamonn R; Lenders, Jacques W M; Eisenhofer, Graeme; Jimenez, Camilo; Pacak, Karel; Pamporaki, Christina.
Afiliación
  • Casey RT; Department of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. rc674@cam.ac.uk.
  • Hendriks E; Department of Endocrinology, Cambridge Cancer Centre and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. rc674@cam.ac.uk.
  • Deal C; Department of Paediatric Diabetes and Endocrinology, Cambridge Cancer Centre and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Waguespack SG; Endocrine and Diabetes Service, CHU Sainte-Justine and University of Montreal, Montreal, Québec, Canada.
  • Wiegering V; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Redlich A; University Children's Hospital, Department of Paediatric Hematology, Oncology and Stem Cell Transplantation, University of Würzburg, Würzburg, Germany.
  • Akker S; Paediatric Oncology Department, Otto von Guericke University Children's Hospital, Magdeburg, Germany.
  • Prasad R; St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
  • Fassnacht M; Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK.
  • Clifton-Bligh R; Department of Medicine, Division of Endocrinology and Diabetes, University Hospital, University of Würzburg, Würzburg, Germany.
  • Amar L; Department of Diabetes and Endocrinology, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Bornstein S; Université de Paris, Paris, France.
  • Canu L; Hypertension Unit, Hôpital Européen Georges Pompidou, Assistance Publique - Hôpitaux de Paris, Paris, France.
  • Charmandari E; Department of Medicine III, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Chrisoulidou A; Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
  • Freixes MC; Centro di Ricerca e Innovazione sulle Patologie Surrenaliche, Azienda Ospedaliera Universitaria (AOU) Careggi, Florence, Italy.
  • de Krijger R; Division of Endocrinology, Metabolism and Diabetes, First Department of Paediatrics, National and Kapodistrian University of Athens Medical School, 'Aghia Sophia' Children's Hospital, Athens, Greece.
  • de Sanctis L; Unit of Endocrinology, Theagenio Hospital, Thessaloniki, Greece.
  • Fojo A; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain.
  • Ghia AJ; Princess Maxima Center for Paediatric Oncology, Utrecht, Netherlands.
  • Huebner A; Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Kosmoliaptsis V; Department of Public Health and Paediatric Sciences, University of Turin, Turin, Italy.
  • Kuhlen M; Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
  • Raffaelli M; Department of Radiation Oncology, University Hospital of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Lussey-Lepoutre C; Department of Paediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Marks SD; Department of Surgery, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK.
  • Nilubol N; Blood and Transplant Research Unit in Organ Donation and Transplantation, National Institute for Health Research, University of Cambridge, Cambridge, UK.
  • Parasiliti-Caprino M; Paediatrics and Adolescent Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
  • Timmers HHJLM; U.O.C. Chirurgia Endocrina e Metabolica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Zietlow AL; Istituto di Semeiotica Chirurgica, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Robledo M; Service de médecine nucléaire, Inserm U970, Sorbonne université, Groupe hospitalier Pitié-Salpétrière, Paris, France.
  • Gimenez-Roqueplo AP; Department of Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust and NIHR GOSH Biomedical Research Centre, University College London Great Ormond Street Institute of Child Health, London, UK.
  • Grossman AB; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Taïeb D; Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti, Turin, Italy.
  • Maher ER; Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, Netherlands.
  • Lenders JWM; Clinical Child and Adolescent Psychology, Institute of Clinical Psychology and Psychotherapy, Department of Psychology, TU Dresden, Dresden, Germany.
  • Eisenhofer G; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain.
  • Jimenez C; Université Paris Cité, PARCC, INSERM, Paris, France.
  • Pacak K; Service de Génétique, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France.
  • Pamporaki C; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.
Nat Rev Endocrinol ; 2024 Aug 15.
Article en En | MEDLINE | ID: mdl-39147856
ABSTRACT
Phaeochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumours that arise not only in adulthood but also in childhood and adolescence. Up to 70-80% of childhood PPGL are hereditary, accounting for a higher incidence of metastatic and/or multifocal PPGL in paediatric patients than in adult patients. Key differences in the tumour biology and management, together with rare disease incidence and therapeutic challenges in paediatric compared with adult patients, mandate close expert cross-disciplinary teamwork. Teams should ideally include adult and paediatric endocrinologists, oncologists, cardiologists, surgeons, geneticists, pathologists, radiologists, clinical psychologists and nuclear medicine physicians. Provision of an international Consensus Statement should improve care and outcomes for children and adolescents with these tumours.
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Nat Rev Endocrinol Asunto de la revista: ENDOCRINOLOGIA Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Nat Rev Endocrinol Asunto de la revista: ENDOCRINOLOGIA Año: 2024 Tipo del documento: Article